Krupa Rajur, MD, CEO & President of C2I Accelerator speaks about C2I's mission
Krupa Rajur, MD, founded C2I Accelerator with Raj Rajur, PhD, with a mission to foster the next generation of entrepreneurs and start-ups...
Dec 26, 2019
IM Therapeutics Raises $10 Million Financing Co-Led by JDRF T1D Fund and Morningside Ventures
IM Therapeutics is a clinical stage company developing personalized therapies for autoimmune disease. On October 9th, they announced that...
Oct 17, 2019
Welcome IM Therapeutics to the C2I Family!
We would love to extend our warm welcome to IM Therapeutics! IM Therapeutics is redefining autoimmunity and transforming lives by...
Oct 16, 2019
